Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
about
The dopamine hypothesis of schizophrenia: version III--the final common pathwayHaloperidol dose for the acute phase of schizophreniaAntipsychotic medication for early episode schizophreniaAtypicality of atypical antipsychotics.Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patternsAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsTrace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical ImplicationsBrain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter SystemsAntipsychotic dosing: found in translationThe risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysisUse of magnetic resonance imaging in pharmacogenomicsNeuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophreniaUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismHow do the atypical antipsychotics work?DISC1: Structure, Function, and Therapeutic Potential for Major Mental IllnessDopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FutureActivation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3Model-based parametric study of frontostriatal abnormalities in schizophrenia patientsThe role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.Dipyridamole monotherapy in schizophrenia: pilot of a novel treatment approach by modulation of purinergic signaling.Disruption of conditioned reward association by typical and atypical antipsychotics.D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.How antipsychotics work-from receptors to reality.The developing utility of zebrafish models for cognitive enhancers researchAntipsychotic dose and diminished neural modulation: a multi-site fMRI study.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.Haloperidol dose for the acute phase of schizophrenia.Antipsychotic drug action: targets for drug discovery with neurochemical imaging.Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literatureThe role of dopamine in reward and pleasure behaviour--review of data from preclinical research.Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychoticsThe impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia.Modern antipsychotic drugs: a critical overviewClassics in Chemical Neuroscience: Aripiprazole.Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.Effect of second-generation antipsychotics on cognition: current issues and future challenges.Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.
P2860
Q22242827-BC54EFDF-66DA-4799-8A73-74EDACC1E23FQ24200200-BA86CF26-9918-414D-A4C5-DB00422BEC13Q24236683-D9ED3EA2-671A-48A8-9153-2EF75F4F64F7Q24535908-6C20D22B-16A1-4B96-8352-301DA7876ECEQ24802626-9B926CF4-7404-4EAF-8D73-3E2630BCC679Q26745506-8B4E9F52-94BA-4588-9E8B-8894DC151F89Q26752602-296769CC-5552-4EEB-A16D-B8E7336DAD13Q26786247-C52AA604-B1BB-4874-988F-500528660A1EQ26863343-D23642CB-C6BF-4E8A-A632-7AADA35AAEB8Q26996493-534AE5D1-3946-4740-B3D2-CDAD56EC6B50Q27011768-DCB573E8-3F69-42C2-A222-41E1BB856508Q27026382-20FA2C1B-999A-4E44-9CB0-A2A5FF45671FQ28084069-6EA0C881-F9A6-4802-8BB5-758AA33B7DA9Q28344179-EA6ED22A-9034-4DF2-9363-A8988A105619Q28393891-0539E1B9-11CE-4031-9E70-C2B3E7384EBDQ28394341-F23D1B41-412C-4539-97AF-B4102AAA711DQ28567705-1BF0188C-C51A-4365-BEAB-F8A6421510EAQ28748228-9E7B1475-458E-4485-9B80-9472028A9B6DQ30251689-82B83C59-3F45-4329-BE9C-C6521E4D95B9Q30438924-372B08CB-B8CC-4C63-8AD5-75982D797558Q30450317-0BCEEE64-440D-4447-8B61-ABE6AF455DA1Q30453020-2A73DC81-7A07-4485-8DD5-1BCA8DA2058BQ30455893-D939813D-84DD-477F-A8B3-481E10F55017Q30457477-261993CC-3646-4F2E-BBDB-715CFB15A893Q30457705-B13ED79B-6EE4-4F68-9454-42A18AE854B2Q30475844-6A9A59A7-FDB7-49C0-9210-C05C0B7ECA73Q30685335-A16398C0-CF33-4EDA-B80B-499D1D2267B6Q30747608-55E05679-4C00-46E1-8311-635F8E325267Q30838771-BE9B14DB-A503-47DE-9283-2FFF1AF48271Q31032036-B33E831D-1233-4EBB-9C18-EF3EB2D2A6C4Q31147797-79F49283-3F89-48F3-969D-00C86FEBB07FQ33214750-64E0416B-79E6-47D5-9941-D18C254B4C2BQ33480027-1D09634C-A91B-41C9-82D9-77063D90AEA2Q33635632-0445762C-774B-4C5A-877F-F94523AF78F6Q33662909-334938C7-986E-483B-99B8-9515C0CD1874Q33853390-00AD5AB2-EEDD-4A09-9FFA-65F94FFD4BC3Q33866125-FED4C118-18BE-4E6B-91E1-3DC2B71B8ECAQ33886277-E6522E88-5BC2-4EE3-94A2-67EE2DEC2E3FQ33888153-B33471F0-1217-4FC4-BFAC-5AC119E53197Q33893744-7A12ABB5-D138-4768-BAAE-05E7D840C4E3
P2860
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Relationship between dopamine ...... f first-episode schizophrenia.
@ast
Relationship between dopamine ...... f first-episode schizophrenia.
@en
Relationship between dopamine ...... f first-episode schizophrenia.
@nl
type
label
Relationship between dopamine ...... f first-episode schizophrenia.
@ast
Relationship between dopamine ...... f first-episode schizophrenia.
@en
Relationship between dopamine ...... f first-episode schizophrenia.
@nl
prefLabel
Relationship between dopamine ...... f first-episode schizophrenia.
@ast
Relationship between dopamine ...... f first-episode schizophrenia.
@en
Relationship between dopamine ...... f first-episode schizophrenia.
@nl
P2093
P1476
Relationship between dopamine ...... f first-episode schizophrenia.
@en
P2093
P304
P356
10.1176/APPI.AJP.157.4.514
P407
P50
P577
2000-04-01T00:00:00Z